Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | AOCI Attributable to Parent | Treasury Stock | Noncontrolling Interest |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | $ 336,017 | $ 17 | $ 313,955 | $ 204,818 | $ (25,805) | $ (154,803) | $ (2,165) |
Shares, Outstanding | | | 17,473,598 | | | | 4,126,132 | |
Beginning Balance (in shares) at Dec. 31, 2017 | | | 17,473,598 | | | | 4,126,132 | |
Beginning Balance at Dec. 31, 2017 | | 336,017 | $ 17 | 313,955 | 204,818 | (25,805) | $ (154,803) | (2,165) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stock-based compensation | | 993 | | 993 | | | | |
Exercise of employee stock options (in shares) | | | 212,789 | | | | 0 | |
Exercise of employee stock options | | 8,820 | $ 1 | 8,819 | | | $ 0 | |
Restricted stock issued (in shares) | | | 20,904 | | | | 3,778 | |
Restricted stock issued | | (237) | | | | | $ (237) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 2,715 | | | | | |
Shares issued for bonus settlement and director stipends | | 150 | | 150 | | | | |
Convertible preferred stock dividends | [1] | (1,089) | | | (1,089) | | | |
Net income attributable to Providence | | 5,430 | | | 5,430 | | | |
Stock repurchase (in shares) | | | | | | | 583,027 | |
Stock repurchase plan | | (36,930) | | | | | $ (36,930) | |
Foreign currency translation adjustments, net of tax | | 1,845 | | | | 1,926 | | (81) |
Net loss from discontinued operations attributable to non-controlling interest | | 296 | | | | | | 296 |
Other | | 49 | | 49 | | | | |
Ending Balance (in shares) at Mar. 31, 2018 | | | 17,710,006 | | | | 4,712,937 | |
Ending Balance at Mar. 31, 2018 | | 321,054 | $ 18 | 323,966 | 214,869 | (23,879) | $ (191,970) | (1,950) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | (237) | | | | | (237) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 336,017 | $ 17 | 313,955 | 204,818 | (25,805) | $ (154,803) | (2,165) |
Shares, Outstanding | | | 17,473,598 | | | | 4,126,132 | |
Beginning Balance (in shares) at Dec. 31, 2017 | | | 17,473,598 | | | | 4,126,132 | |
Beginning Balance at Dec. 31, 2017 | | 336,017 | $ 17 | 313,955 | 204,818 | (25,805) | $ (154,803) | (2,165) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net income attributable to Providence | | 1,371 | | | | | | |
Net loss from discontinued operations attributable to non-controlling interest | | (285) | | | | | | |
Reclassification of translation loss realized upon sale of foreign subsidiary | | 627 | | | | | | |
Ending Balance (in shares) at Sep. 30, 2018 | | | 17,779,646 | | | | 4,968,899 | |
Ending Balance at Sep. 30, 2018 | | 299,831 | $ 18 | 331,947 | 208,589 | (28,102) | $ (210,812) | (1,809) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 336,017 | $ 17 | 313,955 | 204,818 | (25,805) | $ (154,803) | (2,165) |
Shares, Outstanding | | | 17,473,598 | | | | 4,126,132 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 321,054 | $ 18 | 323,966 | 214,869 | (23,879) | $ (191,970) | (1,950) |
Shares, Outstanding | | | 17,710,006 | | | | 4,712,937 | |
Beginning Balance (in shares) at Mar. 31, 2018 | | | 17,710,006 | | | | 4,712,937 | |
Beginning Balance at Mar. 31, 2018 | | 321,054 | $ 18 | 323,966 | 214,869 | (23,879) | $ (191,970) | (1,950) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stock-based compensation | | 3,446 | | 3,446 | | | | |
Exercise of employee stock options (in shares) | | | 53,004 | | | | 0 | |
Exercise of employee stock options | | 2,842 | $ 0 | 2,842 | | | $ 0 | |
Restricted stock issued (in shares) | | | 6,085 | | | | 129 | |
Restricted stock issued | | (329) | | (320) | | | $ (9) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 318 | | | | | |
Shares issued for bonus settlement and director stipends | | 0 | | 0 | | | | |
Convertible preferred stock dividends | [1] | (1,101) | | | (1,101) | | | |
Net income attributable to Providence | | (11,215) | | | (11,215) | | | |
Performance restricted stock issued (in shares) | | | 3,110 | | | | | |
Performance restricted stock issued | | (109) | $ 0 | (109) | | | | |
Stock repurchase (in shares) | | | | | | | 255,692 | |
Stock repurchase plan | | (18,823) | | | | | $ (18,823) | |
Conversion of convertible preferred stock to common stock (in shares) | | | 2,608 | | | | | |
Conversion of convertible preferred stock to common stock | | 100 | | 105 | (5) | | | |
Foreign currency translation adjustments, net of tax | | (3,841) | | | | (3,967) | | 126 |
Other | | (109) | | 79 | | | | (188) |
Ending Balance (in shares) at Jun. 30, 2018 | | | 17,775,131 | | | | 4,968,758 | |
Ending Balance at Jun. 30, 2018 | | 291,915 | $ 18 | 330,009 | 202,548 | (27,846) | $ (210,802) | (2,012) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | (329) | | (320) | | | (9) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 321,054 | $ 18 | 323,966 | 214,869 | (23,879) | $ (191,970) | (1,950) |
Shares, Outstanding | | | 17,710,006 | | | | 4,712,937 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 291,915 | $ 18 | 330,009 | 202,548 | (27,846) | $ (210,802) | (2,012) |
Shares, Outstanding | | | 17,775,131 | | | | 4,968,758 | |
Stock-based compensation | | 1,907 | | 1,907 | | | | |
Exercise of employee stock options (in shares) | | | 500 | | | | 0 | |
Exercise of employee stock options | | 8 | $ 0 | 8 | | | $ 0 | |
Restricted stock issued (in shares) | | | 2,395 | | | | 141 | |
Restricted stock issued | | (10) | | 0 | | | $ (10) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 543 | | | | | |
Shares issued for bonus settlement and director stipends | | 0 | | 0 | | | | |
Convertible preferred stock dividends | [1] | (1,111) | | | (1,111) | | | |
Net income attributable to Providence | | 7,154 | | | 7,154 | | | |
Conversion of convertible preferred stock to common stock (in shares) | | | 1,077 | | | | | |
Conversion of convertible preferred stock to common stock | | 40 | | 42 | (2) | | | |
Foreign currency translation adjustments, net of tax | | (856) | | | | (883) | | 27 |
Net loss from discontinued operations attributable to non-controlling interest | | (177) | | | | | | |
Reclassification of translation loss realized upon sale of foreign subsidiary | | 627 | | | | 627 | | |
Other | | 157 | | (19) | | | | 176 |
Ending Balance (in shares) at Sep. 30, 2018 | | | 17,779,646 | | | | 4,968,899 | |
Ending Balance at Sep. 30, 2018 | | 299,831 | $ 18 | 331,947 | 208,589 | (28,102) | $ (210,812) | (1,809) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | (10) | | 0 | | | (10) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 291,915 | $ 18 | 330,009 | 202,548 | (27,846) | $ (210,802) | (2,012) |
Shares, Outstanding | | | 17,775,131 | | | | 4,968,758 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 299,831 | $ 18 | 331,947 | 208,589 | $ (28,102) | $ (210,812) | $ (1,809) |
Shares, Outstanding | | | 17,779,646 | | | | 4,968,899 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 310,998 | $ 18 | 334,744 | 187,127 | | $ (210,891) | |
Shares, Outstanding | | | 17,784,769 | | | | 4,970,093 | |
Beginning Balance (in shares) at Dec. 31, 2018 | | | 17,784,769 | | | | 4,970,093 | |
Beginning Balance at Dec. 31, 2018 | | 310,998 | $ 18 | 334,744 | 187,127 | | $ (210,891) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stock-based compensation | | 2,103 | | 2,103 | | | | |
Exercise of employee stock options (in shares) | | | 57,022 | | | | | |
Exercise of employee stock options | | 2,557 | | 2,557 | | | | |
Restricted stock issued (in shares) | | | 25,357 | | | | 3,459 | |
Restricted stock issued | | (217) | | | | | $ (217) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 599 | | | | | |
Shares issued for bonus settlement and director stipends | | 0 | | | | | | |
Convertible preferred stock dividends | [2] | (1,087) | | | (1,087) | | | |
Net income attributable to Providence | | 582 | | | 582 | | | |
Ending Balance (in shares) at Mar. 31, 2019 | | | 17,867,747 | | | | 4,973,552 | |
Ending Balance at Mar. 31, 2019 | | 314,936 | $ 18 | 339,404 | 186,622 | | $ (211,108) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | (217) | | | | | (217) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 310,998 | $ 18 | 334,744 | 187,127 | | $ (210,891) | |
Shares, Outstanding | | | 17,784,769 | | | | 4,970,093 | |
Beginning Balance (in shares) at Dec. 31, 2018 | | | 17,784,769 | | | | 4,970,093 | |
Beginning Balance at Dec. 31, 2018 | | 310,998 | $ 18 | 334,744 | 187,127 | | $ (210,891) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net income attributable to Providence | | 7,024 | | | | | | |
Net loss from discontinued operations attributable to non-controlling interest | | 0 | | | | | | |
Reclassification of translation loss realized upon sale of foreign subsidiary | | 0 | | | | | | |
Ending Balance (in shares) at Sep. 30, 2019 | | | 17,967,996 | | | | 5,081,434 | |
Ending Balance at Sep. 30, 2019 | | 319,655 | $ 18 | 346,034 | 190,857 | | $ (217,254) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 310,998 | $ 18 | 334,744 | 187,127 | | $ (210,891) | |
Shares, Outstanding | | | 17,784,769 | | | | 4,970,093 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 314,936 | $ 18 | 339,404 | 186,622 | | $ (211,108) | |
Shares, Outstanding | | | 17,867,747 | | | | 4,973,552 | |
Beginning Balance (in shares) at Mar. 31, 2019 | | | 17,867,747 | | | | 4,973,552 | |
Beginning Balance at Mar. 31, 2019 | | 314,936 | $ 18 | 339,404 | 186,622 | | $ (211,108) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Stock-based compensation | | 1,289 | | 1,289 | | | | |
Exercise of employee stock options (in shares) | | | 67,931 | | | | | |
Exercise of employee stock options | | 3,826 | | 3,826 | | | | |
Restricted stock issued (in shares) | | | 7,088 | | | | 2,419 | |
Restricted stock issued | | (155) | | | | | $ (155) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 202 | | | | | |
Shares issued for bonus settlement and director stipends | | 0 | | | | | | |
Convertible preferred stock dividends | [2] | (1,098) | | | (1,098) | | | |
Preferred stock conversion (in shares) | | | 4,104 | | | | | |
Preferred stock conversion | | 157 | | 157 | | | | |
Net income attributable to Providence | | (1,712) | | | (1,712) | | | |
Ending Balance (in shares) at Jun. 30, 2019 | | | 17,947,072 | | | | 4,975,971 | |
Ending Balance at Jun. 30, 2019 | | 317,243 | $ 18 | 344,676 | 183,812 | | $ (211,263) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | (155) | | | | | (155) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 314,936 | $ 18 | 339,404 | 186,622 | | $ (211,108) | |
Shares, Outstanding | | | 17,867,747 | | | | 4,973,552 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 317,243 | $ 18 | 344,676 | 183,812 | | $ (211,263) | |
Shares, Outstanding | | | 17,947,072 | | | | 4,975,971 | |
Stock-based compensation | | 855 | | 855 | | | | |
Exercise of employee stock options (in shares) | | | 17,755 | | | | | |
Exercise of employee stock options | | 503 | | 503 | | | | |
Restricted stock issued (in shares) | | | 2,313 | | | | 42 | |
Restricted stock issued | | | | | | | $ (3) | |
Shares issued for bonus settlement and director stipends (in shares) | | | 856 | | | | | |
Shares issued for bonus settlement and director stipends | | 0 | | | | | | |
Convertible preferred stock dividends | [2] | (1,109) | | | (1,109) | | | |
Preferred stock conversion (in shares) | | | 0 | | | | | |
Preferred stock conversion | | 0 | | 0 | | | | |
Net income attributable to Providence | | $ 8,154 | | | 8,154 | | | |
Stock repurchase (in shares) | | 105,421 | | | | | | |
Stock repurchase plan | | $ (5,988) | | | | | $ (5,988) | |
Net loss from discontinued operations attributable to non-controlling interest | | 0 | | | | | | |
Reclassification of translation loss realized upon sale of foreign subsidiary | | 0 | | | | | | |
Ending Balance (in shares) at Sep. 30, 2019 | | | 17,967,996 | | | | 5,081,434 | |
Ending Balance at Sep. 30, 2019 | | 319,655 | $ 18 | 346,034 | 190,857 | | $ (217,254) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Restricted stock issued | | | | | | | (3) | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | 317,243 | $ 18 | 344,676 | 183,812 | | $ (211,263) | |
Shares, Outstanding | | | 17,947,072 | | | | 4,975,971 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | | $ 319,655 | $ 18 | $ 346,034 | $ 190,857 | | $ (217,254) | |
Shares, Outstanding | | | 17,967,996 | | | | 5,081,434 | |
| |
[1] | Cash dividends on redeemable convertible preferred stock of $1.36, $1.37, an d $1.37 per share were distributed to convertible preferred stockholders for the three months ended March 31, 2018, June 30, 2018, and September 3 0, 2018, respec tively. | |
[2] | Cash dividends on redeemable convertible preferred stock of $1.36, $1.37, and $1.38 per share were distributed to convertible preferred stockholders for the three months ended March 31, 2019, June 30, 2019, and September 30, 2019, respectively. | |